A photo of Prasad Devarajan.

Director, Division of Nephrology and Hypertension

Medical Director, Stone Center

Louise M. Williams Endowed Chair

Professor, UC Department of Pediatrics



Board Certified

Best Doctors logo

My Biography & Research


As a pediatric nephrologist, I treat children and adolescents who have kidney stones, acute kidney injuries and chronic kidney diseases. I believe that patients always come first, and that patient care is job one.

Although we are a group practice, each one of us is proud and privileged to continuously follow each patient and their family. We provide personalized care to every child. Children can get sick quickly, but with good care they typically recover fast and completely. It’s very rewarding to see a sick child transformed into a healthier kid as a result of our good care in partnership with their family.

Children are not consumers or customers — their health is our responsibility. We are more than providers. We are privileged to have the honor and responsibility for their care, to cure their diseases and to help them maintain good health. We also continuously pursue clinical excellence with our innovative research.

I have authored about 300 peer-reviewed publications and 70 book chapters, and I have delivered more than 200 invited lectures internationally. My research activities have been continuously funded by the National Institutes of Health (NIH) and other agencies for more than 30 years. This work spans the spectrum of highly collaborative basic, translational and clinical inquiries, all focused on improving child health. I have consistently been listed in Thomson Reuters "World's Most Influential Scientific Minds" in recognition of ranking among the top 1% of researchers for most cited publications in the entire field of medicine.

In my research, we are actively investigating mechanisms that cause the kidney to fail acutely and chronically. The results of these investigations are providing us with novel biomarkers to predict kidney disease, and also with new pathways we can target with innovative therapies. We are at the forefront nationally and internationally in the care of children with kidney disease.

In my free time, I practice meditation and deep reflection. I also love taking long walks with my dog.

Additional Languages


Academic Affiliation

Professor, UC Department of Pediatrics

Clinical Divisions

Nephrology and Hypertension, Kidney Transplant, Kidney Disease, End-Stage Renal Disease, Lupus, Nephrology - Acute Care, Kidney Stones

Research Divisions

Nephrology and Hypertension, Developmental Biology, Fibrosis

Blog Posts

Kidney Stones: Not Just An Adult Problem

BlogHealthy Living

Kidney Stones: Not Just An Adult Problem

By Dr. Prasad Devarajan3/25/2019

My Locations

My Education

Premedical Studies: Bombay University, India, 1979.

MD: Bombay University, India, 1985.

My Publications

The Current State of the Art in Acute Kidney Injury. Devarajan, P. Frontiers in Pediatrics. 2020; 8.

Juvenile OLFM4-null mice are protected from sepsis. Stark, JE; Opoka, AM; Mallela, J; Devarajan, P; Ma, Q; Levinsky, NC; Stringer, KF; Wong, HR; Alder, MN. AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY. 2020; 318:F809-F816.

Post-Acute Kidney Injury Proteinuria and Subsequent Kidney Disease Progression The Assessment, Serial Evaluation, and Subsequent Sequelae in Acute Kidney Injury (ASSESS-AKI) Study. Hsu, C; Chinchilli, VM; Coca, S; Devarajan, P; Ghahramani, N; Go, AS; Hsu, RK; Ikizler, TA; Kaufman, J; Liu, KD; et al. JAMA Internal Medicine. 2020; 180:402-410.

Association of Serum Uromodulin With ESKD and Kinney Function Decline in the Elderly: The Cardiovascular Health Study. Steubl, D; Buzkova, P; Garimella, PS; Ix, JH; Devarajan, P; Bennett, MR; Chaves, PH M; Shlipak, MG; Bansal, N; Sarnak, MJ. American Journal of Kidney Diseases. 2019; 74:501-509.

Molecular nephrology: types of acute tubular injury. De Oliveira, BD; Xu, K; Shen, TH; Callahan, M; Kiryluk, K; D'Agati, VD; Tatonetti, NP; Barasch, J; Devarajan, P. Nature Reviews Nephrology. 2019; 15:599-612.

Inhibition of fibronectin polymerization alleviates kidney injury due to ischemia-reperfusion. Bowers, SL K; Davis-Rodriguez, S; Thomas, ZM; Rudomanova, V; Bacon, WC; Beiersdorfer, A; Ma, Q; Devarajan, P; Blaxall, BC. AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY. 2019; 316:F1293-F1298.

Haptoglobin degradation product as a novel serum biomarker for hematopoietic stem cell transplant-associated thrombotic microangiopathy. Schuh, MP; Bennett, MR; Lane, A; Jodele, S; Laskin, BL; Devarajan, P. Pediatric Nephrology. 2019; 34:865-871.

Proteomic profiling of urine: implications for lupus nephritis. Aljaberi, N; Bennett, M; Brunner, HI; Devarajan, P. Expert Review of Proteomics. 2019; 16:303-313.

Identification of Urinary CD44 and Prosaposin as Specific Biomarkers of Urinary Tract Infections in Children With Neurogenic Bladders. Forster, CS; Haffey, WD; Bennett, M; Greis, KD; Deyarajan, P. Biomarker Insights. 2019; 14:1177271919835570-117727191983557.

Discovery of SERPINA3 as a candidate urinary biomarker of lupus nephritis activity. Turnier, JL; Brunner, HI; Bennett, M; Aleed, A; Gulati, G; Haffey, WD; Thornton, S; Wagner, M; Devarajan, P; Witte, D; et al. Rheumatology. 2019; 58:321-330.